Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRobinson Regulatory News (RBN)

Share Price Information for Robinson (RBN)

Share Price is delayed by 15 minutes
Get Live Data
130.00    0.00 (0.00%)
Bid:
125.00
Ask:
135.00
Spread: 10.00 (8.00%)
Market Cap: £21.78m
RBN Live PriceLast checked at - London Stock Exchange

Intraday Robinson Share Chart

Surplus Property Update

19 Mar 2026 07:00

RNS Number : 2149X
Robinson PLC
19 March 2026
 

 

Robinson plc

19 March 2026

 

SURPLUS PROPERTY UPDATE

 

Robinson plc ("Robinson", the "Company" or the "Group"; stock code: RBN), the custom manufacturer of plastic and paperboard packaging, is pleased to provide an update on the status of the divestment of the Company's surplus properties.

 

In line with our Surplus Property Update on 7 August 2025, the Company is pleased to announce the completion of the sale of c.1.3 acres of the Walton Works surplus property. Contracts were exchanged on 13 August 2023 and following satisfactory completion of the necessary conditions, including receipt of full planning approval, completion took place on 18 March 2026. The gross consideration payable was previously anticipated to be £1,029,000 with expected costs of £429,000. The final costs of £412,335 will be borne by the buyer, therefore, the consideration payable at completion was £616,665, which will be used to reduce current bank debt. The majority of the property was vacant with a small part periodically let to third parties on short term tenancies. The property attracted rental income of £7,000 during 2025 and the book value was £540,000 at 31 December 2025. 

 

The intention of the Group remains, over time, to realise value from the disposal of surplus properties and use the proceeds to reduce indebtedness and develop our packaging business.

 

For further information, please contact:

 

Robinson plc

www.robinsonpackaging.com

John Melia, CEO

Mike Cusick, CFO

Tel: 01246 389280

Cavendish Capital Markets Limited

Ed Frisby / Seamus Fricker, Corporate Finance

Ella Bedford, Corporate Broking

Tel: 020 7220 0500

 

About Robinson:

 

Being a purpose-led business, Robinson specialises in custom packaging with technical and value-added solutions for food and consumer product hygiene, safety, protection, and convenience; going above and beyond to create a sustainable future for our people and our planet. Its main activity is in injection and blow moulded plastic packaging and rigid paperboard luxury packaging, operating within the Food, Homecare, Personal care, and Luxury gift sectors. Robinson provides products and services to major players in the fast-moving consumer goods market including Bakkavor, British Pepper & Spice, McBride, Persan, Procter & Gamble and Unilever.

 

Headquartered in Chesterfield, UK, Robinson has plants in the UK, Poland and Denmark. Robinson was formerly a family business with its origins dating back to 1839, currently employing nearly 400 people. The Group has an ongoing disposal programme for its substantial surplus property portfolio with development potential.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBIGDXDBBDGLI
Date   Source Headline
24th Jun 20217:00 amRNSAGM Trading Statement
16th Jun 20211:15 pmRNSAGM - Change Of Format
15th Apr 202111:00 amRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSFinal Results
1st Mar 20217:00 amRNSAcquisition Funding Update
11th Feb 20217:00 amRNSAcquisition
21st Jan 20217:00 amRNSTrading Statement
18th Aug 20207:00 amRNSInterim Results
17th Jul 202010:49 amRNSGrant of Options & PDMR Dealing
30th Jun 20201:30 pmRNSResult of AGM
30th Jun 20207:00 amRNSAGM Statement
8th Jun 20209:11 amRNSNotice of AGM
17th Apr 20203:50 pmRNSDirector/PDMR Shareholding
1st Apr 20207:00 amRNSFinal Results
26th Mar 20206:28 pmRNSDelay in the publication of Financial Statements
12th Dec 20197:00 amRNSTrading Statement
29th Aug 201910:14 amRNSHolding(s) in Company
21st Aug 20197:00 amRNSInterim Results
20th Aug 20197:00 amRNSChief Executive Appointment
18th Jul 20194:00 pmRNSDirector/PDMR Shareholding
20th May 201910:41 amRNSHolding(s) in Company
9th May 20194:28 pmRNSResult of AGM
9th May 20197:00 amRNSAGM Statement
22nd Mar 20197:00 amRNSFinal Results
21st Jan 20197:00 amRNSTrading Statement
31st Dec 20187:00 amRNSDirector Appointments
7th Dec 20187:00 amRNSBoard Appointments
3rd Dec 20183:42 pmRNSCEO Announcement
22nd Aug 20187:00 amRNSHalf-year Report
22nd May 20188:57 amRNSDirector/PDMR Shareholding
10th May 20184:42 pmRNSResult of AGM
10th May 20187:00 amRNSAGM Statement
25th Apr 20189:58 amRNSDirector/PDMR Shareholding
25th Apr 20187:00 amRNSDirector/PDMR Shareholding
23rd Mar 20187:00 amRNSFinal Results
21st Dec 201711:36 amRNSTrading Statement
23rd Aug 20177:00 amRNSInterim Results
11th May 20173:13 pmRNSResult of AGM
11th May 20177:00 amRNSAGM Trading Statement
3rd Apr 201710:16 amRNSDirector Dealing and Holdings in Company
30th Mar 20177:00 amRNSDirector Dealings and Total Voting Rights
24th Mar 20177:00 amRNSFinal Results
12th Jan 20177:00 amRNSTrading Statement and Planning Approval
17th Aug 20167:00 amRNSHalf Yearly Report
9th Jun 20162:36 pmRNSDirector Dealing
18th May 20165:04 pmRNSDirector Dealing
5th May 20161:36 pmRNSResult of AGM
5th May 20167:00 amRNSAGM Trading Statement
18th Mar 20167:00 amRNSPreliminary Results
25th Jan 20167:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.